click below
click below
Normal Size Small Size show me how
BDK Endocrine #1
Basic Drug Knowledge Endocrine Page #1
| Generic Name | Brand Name | Classification | Pharmacologic Category | Common Indications | Key Side Effects | US Boxed Warnings | Other Notes |
|---|---|---|---|---|---|---|---|
| Metformin (PO) | Fortamet, Glumetza, Riomet | Biguanide | Type 2 Diabetes Mellitus (DM), Polycystic Ovarian Syndrome (PCOS) | Diarrhea, Nausea, Vomiting, Vitamin B12 Deficiency | Lactic Acidosis | CI with eGFR <30 | |
| Sitagliptin (PO) | Januvia, Zituvio | Dipeptidyl Peptidase (DPP-4) Inhibitor | Type 2 Diabetes Mellitus (DM) | Nasopharyngitis | |||
| Empagliflozin (PO) | Jardiance | Sodium-Glucose Cotransporter Inhibitor 2 (SGLT2 Inhibitor) | Type 2 Diabetes Mellitus (DM), Heart Failure (HF), Chronic Kidney Disease (CKD) | Genital Mycotic Infections, UTI | |||
| Dapagliflozin (PO) | Farxiga | Sodium-Glucose Cotransporter Inhibitor 2 (SGLT2 Inhibitor) | Type 2 Diabetes Mellitus (DM), Heart Failure (HF), Chronic Kidney Disease (CKD) | Genital Mycotic Infections, UTI | |||
| Glimepiride (PO) | Amaryl | Sulfonylurea | Type 2 Diabetes Mellitus (DM) | Hypoglycemia, Weight Gain | |||
| Glipizide (PO) | Glucotrol, Glucotrol XL | Sulfonylurea | Type 2 Diabetes Mellitus (DM) | Hypoglycemia, Weight Gain | |||
| Pioglitazone (PO) | Actos | Thiazolidinedione (TZD) | Type 2 Diabetes Mellitus (DM) | Peripheral Edema, Weight Gain, Upper Respiratory Tract Infection; Increased Risk of Fratures & Bladder Cancer | May exacerbate congestive heart failure & CI in NYHA Class III & IV | ||
| Dulaglutide (SQ) | Trulicity | Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist | Type 2 Diabetes Mellitus (DM) | Nausea, Vomiting, Diarrhea, Pancreatitis | May increase risk of thyroid c-cell tumor, CI in personal or family history of medullary thyroid cancer & in patients with multiple endocrine neoplasia syndrome type 2 | ||
| Liraglutide (SQ) | Victoza, Saxenda | Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist | Type 2 Diabetes Mellitus (DM), Chronic Weight Management | Nausea, Vomiting, Diarrhea, Constipation, Pancreatitis | May increase risk of thyroid c-cell tumor, CI in personal or family history of medullary thyroid cancer & in patients with multiple endocrine neoplasia syndrome type 2 | ||
| Semaglutide (PO, SQ) | SQ: Ozempic, Wegovy PO: Rybelsus, Wegovy | Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist | Type 2 Diabetes Mellitus (DM), Chronic Weight Management | Nausea, Vomiting, Diarrhea, Constipation, Pancreatitis | May increase risk of thyroid c-cell tumor, CI in personal or family history of medullary thyroid cancer & in patients with multiple endocrine neoplasia syndrome type 2 | ||
| Tirzepatide (SQ) | Mounjaro, Zepbound | Dual GLP-1 and Glucose-Dependent Insulinotropic Polypeptide (GIP) Agonist | Type 2 Diabetes Mellitus (DM), Chronic Weight Management | Nausea, Vomiting, Diarrhea, Constipation, Increased Heart Rate, Pancreatitis | May increase risk of thyroid c-cell tumor, CI in personal or family history of medullary thyroid cancer & in patients with multiple endocrine neoplasia syndrome type 2 | ||
| Insulin Glargine (SQ) | Lantus, Toujeo, Basaglar | Insulin, Long Acting | Type 1 Diabetes Mellitus (DM), Type 2 Diabetes Mellitus (DM) | Hypoglycemia, Weight Gain | |||
| Insulin NPH (SQ) | Humulin N, Novolin N | OTC | Insulin, Intermediate Acting | Type 1 Diabetes Mellitus (DM), Type 2 Diabetes Mellitus (DM) | Hypoglycemia, Weight Gain | ||
| Insulin Aspart (SQ) | Novolog, Fiasp | Insulin, Rapid Acting | Type 1 Diabetes Mellitus (DM), Type 2 Diabetes Mellitus (DM) | Hypoglycemia, Weight Gain | |||
| Insulin Lispro (SQ) | Humalog, Admelog, Lyumjev | Insulin, Rapid Acting | Type 1 Diabetes Mellitus (DM), Type 2 Diabetes Mellitus (DM) | Hypoglycemia, Weight Gain | |||
| Insulin Regular (SQ, IV) | Humulin R, Novolin R | SQ: OTC | Insulin, Short-Acting | Type 1 Diabetes Mellitus (DM), Type 2 Diabetes Mellitus (DM), Diabetic Ketoacidosis (DKA) | Hypoglycemia, Weight Gain |